Bellerophon Therapeutics Inc (NASDAQ:BLPH)

Delayed Data
As of Jan 22
 +0.14 / +1.80%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Bellerophon Therapeutics Inc have a median target of 26.00, with a high estimate of 35.00 and a low estimate of 19.00. The median estimate represents a +230.37% increase from the last price of 7.87.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Bellerophon Therapeutics Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 18

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -7.74%
Growthannually -14.83%


Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.